Our analysis pipeline covers more than 30 ASX-listed companies over the reporting season so far, across financials, resources, REITs, technology, and industrials. When we ranked them by business quality and then cross-referenced valuation gaps, a pattern emerged that was too consistent to ignore: the highest-quality businesses are also currently amongst the most overvalued.

Pro Medicus and Commonwealth Bank of Australia currently rank amongst the highest in the group so far, with their respective share prices trading several multiples above their intrinsic valuation. Meanwhile, the largest upside sits with Viva Leisure (~52% below its valuation), Reckon (~30% below its valuation), and Amotiv (~28% below its valuation). At the same time, all three stocks also feature Quality ratings at moderate levels. It might appear that the market is currently systematically paying more for quality at the upper tiers, than the quality is actually worth.

This is not a case of two or three outliers. The data table below covers every company in our universe, sorted by quality score.

The Scorecard

The pattern is visible without statistics. The top five companies by quality (PME, DPM, CBA, CPU, IAG) average a valuation gap of negative 35%, meaning overvalued by a third. The bottom five by quality (HUM, BTI, RG1, RKN, AOV) average a gap of positive 11%, meaning modestly undervalued. Two companies break the pattern cleanly: CPU and IAG, both high quality (7.8 and 7.6 respectively) and both trading near fair value. Every other company above 7.0 quality is overvalued, most by 25% or more.

The relationship is not perfectly linear. humm Group, the lowest-quality name in the set at 4.4, is 34% overvalued — a clear counterexample. And among lower-quality names, the gold miners (NST at −60%, EVN at −65%) and diversified miners (S32 at −48%) are heavily overvalued, though for commodity-price-regime reasons rather than narrative premium. But the direction of the relationship is clear, particularly once sector-specific distortions are accounted for.

The Extremes: What Premium Quality Costs

Pro Medicus: 8.4 Quality, 61% Overvalued

PME is the highest-quality business in the pipeline, tied with DPM. ROIC exceeds 200% on an asset-light model, EBIT margins sit at 73–74%, revenue growth is running at 29%, and the company holds a contracted backlog exceeding A$1 billion. Eleven of the top 20 US hospitals use the Visage 7 platform. It has zero debt and A$222 million in cash.

None of that is in dispute. The question is what you pay for it. At A$138.46, the market embeds sustained 30%+ growth at peak margins for 15 or more years. Our 10-year DCF, modelling 22% revenue CAGR decelerating to 3.5% terminal growth, produces a fair value of A$54. That is not a conservative estimate; it gives PME credit for being one of the best software businesses on the ASX. It simply does not give it credit for being one of the best software businesses that has ever existed, which is what the current price requires.

The H1 FY26 result on February 12 illustrated the sensitivity: revenue missed consensus by 2% and EBIT by 10%, and the stock dropped 14.9% in a single session. When a company is priced for perfection, anything less than perfection is repriced severely.

Read the full PME analysis

CBA: 7.8 Quality, 55% Overvalued

CBA is the highest-quality bank in Australia by almost every measure. ROE of 13.8%, cost-to-income ratio of 44.7% (peer-leading), 25% home loan market share, and an 8–10 year competitive advantage period driven by digital platform investment. It scored 7.8 on our framework, equal to Computershare and above IAG, CSL, and Origin.

At A$171 (now closer to A$178 after a 10.9% rally on 1H26 results), CBA trades at 123% premium to our fair value of A$77. To put that in concrete terms: CBA's current market capitalisation implies the bank will sustain 13.8% ROE indefinitely while growing book value at 5–6% per year with zero reversion to mean. Australian bank ROEs have averaged 11–12% over the cycle. At A$171, the market needs CBA to permanently outperform its own history by 200 basis points.

For comparison, ANZ earns an 8.1% ROE and trades at a 46% premium. CBA earns a higher ROE but also trades at a larger premium. The market charges more per unit of ROE for CBA than for any other bank, which reflects CBA's quality advantage, but the magnitude of the premium has disconnected from what the fundamentals can sustain.

Read the full CBA analysis

DPM Metals: 8.4 Quality, 54% Overvalued

DPM shares PME's quality score and a similar valuation gap, but the driver is different. PME is overvalued because the market capitalises growth optionality at full value. DPM is overvalued because gold sits at US$5,110 per ounce and the market prices that as permanent. Our model uses a base case of approximately US$2,750 per ounce and assigns 35% probability to cyclical mean-reversion. The entire 54% gap is a commodity price regime disagreement. The business underneath, with 11 consecutive years meeting production guidance, 62% EBITDA margins, and a 10–12 year competitive advantage period, is genuinely excellent.

It is worth noting that DPM is not alone in this regard. The gold and copper miners in the pipeline — Evolution Mining (−65%), Northern Star (−60%), and South32 (−48%) — are all overvalued primarily because of the same commodity price assumption, not because of the narrative and passive flow dynamics that drive the premium in names like PME and CBA. When interpreting the aggregate quality-valuation relationship, this commodity-linked cohort should be considered a distinct driver of overvaluation rather than evidence of the same structural forces.

Read the full DPM analysis

The Other Side: What Mediocre Quality Offers

Viva Leisure: 5.9 Quality, 107% Undervalued

VVA is the mirror image of the quality premium trade. A 5.9 quality score reflects real limitations: micro-cap illiquidity, AASB16 accounting confusion that makes institutional investors uncertain about true leverage, and a business that until recently was an acquisition-led roll-up. These are legitimate concerns.

But the market prices VVA at 4.5x EV/EBITDA against a global fitness peer median of 10x, despite 17.6% organic revenue growth, 21.8% EBITDA margins, and an approximately 25% adjusted free cash flow yield. Even our bear case of A$2.30 sits 41% above the current price. The expected return is 27% annualised over three years. The accounting interpretation debate, specifically whether A$271 million in lease liabilities should be deducted from enterprise value, is the single largest source of the gap.

Read the full VVA analysis

Amotiv: 5.3 Quality, 38% Undervalued

AOV scores low on quality because it is a mid-tier automotive aftermarket business with A$888 million in intangibles and customer concentration risk. These are real weaknesses. But the company generates approximately A$96 million in free cash flow at an 11.3% yield to market capitalisation. Our probability-weighted analysis assigns 30% to bear and severe outcomes versus the 45% the market implies, a disagreement worth approximately A$3.27 per share. The expected return is 11.5% annualised.

Read the full AOV analysis

Reckon: 5.1 Quality, 42% Undervalued

RKN is a small, below-average-quality software business with a mature AU/NZ accounting franchise generating A$7–9 million annual free cash flow from 100,000+ sticky subscribers. The market prices it at 7x post-development EBITDA, implying near-zero growth, and assigns effectively no value to the Legal Group scaling optionality (Billing Workflows grew 111% year-on-year). Expected return is approximately 7% annualised including a 3.8% dividend yield, with asymmetric upside if the Legal Group scales or a takeover materialises.

Read the full RKN analysis

Why This Happens

The pattern is not random. Three structural forces push quality premiums beyond what fundamentals support — though they do not explain every overvalued name in the pipeline.

Passive index flows. CBA represents approximately 9% of the ASX200 by weight. Every dollar flowing into an ASX index fund buys A$0.09 of CBA regardless of valuation. PME, as a high-growth compounder, attracts similar passive momentum. Index inclusion creates a self-reinforcing loop: price rises, weight increases, more passive dollars flow in, price rises further. The process is valuation-indifferent. Lower-quality companies with smaller index weights receive proportionally less of this flow.

Retail scarcity bidding. CBA has over 800,000 direct shareholders. PME has become a retail favourite on the basis of its growth profile. When investors scan the ASX for “quality compounders,” these names surface immediately. The perceived scarcity of genuinely high-quality businesses on the ASX concentrates demand into a small number of names, bidding them above fair value. Businesses like VVA and RKN, with lower profiles and smaller market capitalisations, do not attract this flow.

Narrative premium. Quality businesses generate better narratives. “Cloud-native imaging platform with 73% margins and 100% renewal rates” is a more compelling story than “automotive aftermarket group with A$888 million in intangibles.” Investors anchor to narrative quality and extrapolate it into perpetual outperformance. The market implicitly treats business quality as a sufficient condition for investment quality, when it is a necessary but not sufficient condition. Price matters.

Commodity regime assumptions. A fourth force operates distinctly from the above three. The gold and copper miners — DPM, EVN, NST, and to a lesser extent S32 — are overvalued not because of narrative momentum or passive flows, but because the market prices current spot commodity prices as permanent. Our models incorporate mean-reversion probabilities that the market does not, producing large valuation gaps. This is a fundamentally different type of overvaluation: a disagreement about commodity cycles rather than about the price of quality.

These forces are well-known individually. What the pipeline data shows is the aggregate effect: across 31 companies, quality and overvaluation have a positive correlation that is too consistent to be coincidental, even after accounting for the distinct commodity-price driver.

The Exceptions Prove the Rule

Two high-quality companies trade at or near fair value, and they illustrate what quality at a reasonable price looks like.

Computershare (7.8 quality, −2% gap) is the world's largest transfer agent with ROIC above 35%, 95%+ free cash flow conversion, and oligopolistic market positions. The market prices it correctly at approximately A$31.60 fair value against A$32.30 current price. CPU does not attract the same narrative premium as PME or CBA because its business, transfer agency and corporate trust, is less visible to retail investors. The lack of a compelling retail narrative is, paradoxically, what keeps its valuation anchored to fundamentals.

IAG (7.6 quality, −4% gap) is Australia's largest general insurer with widening moats, a 7–10 year competitive advantage period, and margin improvement from 13.7% to 15.5%. Base case fair value is A$7.05 but meaningful downside tail risks (35% combined bear and severe probability) pull the blended fair value to A$6.65, close to the A$6.94 price. IAG is high quality at a fair price, offering total returns of 1–2% above dividends. Not exciting, but correctly priced.

These two companies show that the market is capable of pricing quality correctly. It simply does not do so when narrative momentum, passive flows, or retail scarcity enter the equation.

What the Quality Premium Costs in Practice

To make the quality premium concrete, consider what CBA needs to deliver to justify A$171.

CBA currently earns a 13.8% ROE on approximately A$70 in book value per share. At A$171, the market is paying 2.4x book. For that price to deliver even a 10% total return over five years (roughly cost of equity), CBA would need to grow book value at 6% annually while maintaining 13.8% ROE and paying a 4% dividend yield. That implies zero credit cycle normalisation, no NIM compression, and no ROE mean-reversion over a five-year period. Australian bank ROEs have not held above 13% for five consecutive years since the pre-GFC era.

Now consider what CPU delivers at fair value. CPU earns ROIC above 35% and trades at A$32.30. A 10% total return over five years requires mid-single-digit earnings growth and stable margins, both of which management is currently delivering. The hurdle rate for satisfactory returns is dramatically lower because the starting valuation is reasonable.

The quality premium means paying A$171 for a 7.8-quality bank that must execute flawlessly, or paying A$32.30 for a 7.8-quality financial infrastructure business that must simply continue doing what it is already doing. The quality is identical. The risk-reward is not.

What Would Change Our View

On overvalued quality (PME, CBA, DPM, BRG, SGH): Price declines of 25–40% would bring these companies into ranges where the quality premium is reasonable rather than extreme. PME below A$80, CBA below A$120, and BRG below A$25 would warrant fresh analysis. Alternatively, if PME sustains 30%+ growth for another two to three years while maintaining margins, or if CBA's ROE structurally shifts above 15%, the fair values would need to move higher. We would also revisit the gold miners if structural demand (central bank buying, electrification) establishes a permanently higher floor above US$3,500.

On undervalued mediocrity (VVA, AOV, RKN, AGL): The BUY ratings assume the market is over-discounting legitimate risks. If VVA's AASB16 lease liabilities prove to be a genuine balance sheet problem rather than an accounting interpretation issue, fair value collapses toward A$1.50. If AOV's intangible-heavy balance sheet results in impairments, the downside is material. These are not risk-free positions; they are positions where the compensation for bearing risk appears adequate.

The Bottom Line

The pipeline's quality scores measure genuine business attributes: competitive position, moat duration, management execution, financial health, and earnings quality. A score of 8.4 for PME reflects a business that is measurably better than a 5.3 for AOV. That is not in question.

What is in question is whether the market charges the right price for that quality difference. The data across 31 companies suggests it does not. The top five companies by quality average a valuation gap of −35% (overvalued by a third). The bottom five average +11% (modestly undervalued). Broadening to the top and bottom ten, the pattern persists but becomes messier: the top ten average approximately −25%, while the bottom ten average approximately −8% — still overvalued, but materially less so. The difference is driven partly by commodity-linked names in the lower half (NST, S32, ANZ) whose overvaluation stems from commodity price assumptions rather than narrative premium. Notably, every company rated BUY in the pipeline scores below 6.5 on quality, with the exceptions of DXI (7.4) and CIP (7.5) in the industrial REIT space.

The two companies that sit at the intersection, high quality at fair value, are CPU and IAG. They demonstrate what the market is capable of when narrative momentum and passive flows are absent.

Quality deserves a premium. An excellent business with a wide moat, high returns on capital, and durable competitive advantages is worth more per dollar of earnings than a mediocre business with thin margins and cyclical exposure. The question is how much more, and the current ASX market is answering “infinitely more.” That is the puzzle. Quality is not a guarantee of investment returns at any price. Even the best business in Australia has a price above which it becomes a poor investment.

The few opportunities in the pipeline that combine reasonable quality with genuine undervaluation — VVA at 107% upside, AOV at 38%, RKN at 42%, AGL at 17% — are all businesses with real warts. They require accepting lower quality scores, messier narratives, and less institutional comfort. The market rewards comfort and punishes complexity, and right now that preference has pushed quality premiums to levels where the highest-quality businesses offer the worst prospective returns.